nitinol has been researched along with Hematuria* in 3 studies
3 other study(ies) available for nitinol and Hematuria
Article | Year |
---|---|
Percutaneous nitinol stent implantation in the treatment of nutcracker syndrome in young adults.
The present report describes three young adults with nutcracker syndrome caused by left renal vein stenosis managed with nitinol stent implantation. The patients treated included a 20-year-old woman with persistent microhematuria and dyspareunia and two 18-year-old men with proteinuria, hematuria, and flank pain. All three patients were asymptomatic after a follow-up of 14-18 months. Topics: Adolescent; Adult; Alloys; Aorta, Abdominal; Constriction, Pathologic; Drug-Eluting Stents; Dyspareunia; Female; Hematuria; Humans; Male; Mesenteric Artery, Superior; Peripheral Vascular Diseases; Proteinuria; Renal Veins | 2007 |
Stents for prostatic diseases: any progress after 25 years?
Topics: Alloys; Equipment Safety; Foreign-Body Migration; Hematuria; Humans; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Prosthesis Design; Stents; Urinary Incontinence; Urination | 2006 |
The bell-shaped nitinol prostatic stent in the treatment of lower urinary tract symptoms: experience in 108 patients.
To assess the efficacy, safety, and durability of the bell-shaped nitinol prostatic stent in the treatment of moderate to severe lower urinary tract symptoms caused by benign prostatic enlargement in otherwise healthy patients.. Stents were inserted in an outpatient setting under local anaesthesia. Assessments included maximum urinary flow (Qmax), postvoid residual (PVR) urine volume, International Prostate Symptom Score (IPSS), including quality of life (QoL) item, at baseline and follow-up visits.. 108 men were enrolled in the trial. Stents were successfully inserted in 97% of the patients. Spontaneous voiding was achieved in all patients. After one month Qmax (+3.7 ml/s), PVR (-99 ml), IPSS (-12) and QoL (-1.7) all showed statistically significant improvements compared to baseline. Substantial improvements, however, were maintained for only one to two months. The main complications were haematuria (19%), urge incontinence (22%), and migration (15%). The median indwelling time was 105 days. The main reason for removal of stents was worsening of symptoms, which might be attributable to the tilting of stents within the prostatic urethra, found upon removal.. Insertion of the bell-shaped nitinol prostatic stent temporarily improves voiding parameters and symptom scores. Because of the limited durability, however, the bell-shaped prostatic stent is not suitable for clinical practice. Topics: Aged; Alloys; Device Removal; Equipment Safety; Follow-Up Studies; Foreign-Body Migration; Hematuria; Humans; Male; Middle Aged; Prospective Studies; Prosthesis Design; Quality of Life; Severity of Illness Index; Stents; Survival Analysis; Time Factors; Treatment Outcome; Urinary Incontinence; Urination; Urologic Diseases; Urologic Surgical Procedures, Male | 2006 |